PMV Pharmaceuticals, Inc. (PMVP)
1.27
-0.04
(-2.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals Price : 1.27 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.30 | 1.33 | 1.255 | 1.27 | 171002.0 |
| Oct 22, 2026 | 1.36 | 1.37 | 1.30 | 1.305 | 128614.0 |
| Oct 21, 2026 | 1.37 | 1.41 | 1.35 | 1.36 | 236574.0 |
| Oct 20, 2026 | 1.26 | 1.41 | 1.26 | 1.39 | 347585.0 |
| Oct 19, 2026 | 1.21 | 1.29 | 1.21 | 1.255 | 195978.0 |
| Oct 16, 2026 | 1.28 | 1.30 | 1.20 | 1.21 | 357647.0 |
| Oct 15, 2026 | 1.26 | 1.33 | 1.24 | 1.29 | 376586.0 |
| Oct 14, 2026 | 1.33 | 1.37 | 1.23 | 1.24 | 525843.0 |
| Oct 13, 2026 | 1.40 | 1.466 | 1.315 | 1.35 | 542756.0 |
| Oct 12, 2026 | 1.55 | 1.55 | 1.40 | 1.41 | 398621.0 |
| Oct 09, 2026 | 1.49 | 1.61 | 1.48 | 1.52 | 891744.0 |
| Oct 08, 2026 | 1.51 | 1.54 | 1.46 | 1.49 | 461395.0 |
| Oct 07, 2026 | 1.59 | 1.60 | 1.48 | 1.50 | 607439.0 |
| Oct 06, 2026 | 1.78 | 1.81 | 1.591 | 1.61 | 616109.0 |
| Oct 05, 2026 | 1.80 | 1.84 | 1.70 | 1.78 | 1.185M |
| Oct 02, 2026 | 1.75 | 1.87 | 1.68 | 1.79 | 3.736M |
| Oct 01, 2026 | 1.68 | 1.91 | 1.63 | 1.75 | 1.647M |
| Sep 30, 2026 | 1.44 | 1.725 | 1.44 | 1.67 | 3.125M |
| Sep 29, 2026 | 1.37 | 1.45 | 1.36 | 1.43 | 550860.0 |
| Sep 28, 2026 | 1.34 | 1.39 | 1.30 | 1.36 | 341564.0 |
| Sep 25, 2026 | 1.32 | 1.38 | 1.29 | 1.33 | 271150.0 |
| Sep 24, 2026 | 1.36 | 1.40 | 1.28 | 1.335 | 486346.0 |
| Sep 23, 2026 | 1.51 | 1.52 | 1.365 | 1.37 | 574275.0 |
| Sep 22, 2026 | 1.47 | 1.525 | 1.46 | 1.51 | 316918.0 |
| Sep 21, 2026 | 1.50 | 1.51 | 1.445 | 1.475 | 329961.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| Price to Book Value | 0.9496 |
| Earnings Yield | -111.3% |
| Market Cap | 67.89M |